Lesion size

Biomarker

1 paper1 finding

  • Animals1

Interventions

1

Navitoclax

no changein mice1

1 study
  1. Navitoclax has no effect on lesion size in mice.

    “ABT-263 treatment did not change lesion size or lumen area of the brachiocephalic artery (BCA).”

    Animalsin western diet-fed Apoe-/- mice with advanced atherosclerosisbrachiocephalic artery100 mg/kg/bw or 50 mg/kg/bw6 weeks or 9 weeks

    Treatment of advanced atherosclerotic mice with ABT-263 reduced indices of plaque stability and increased mortality

    JCI insight23 Jan 2024

More on Navitoclax

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 2Sep 2026: 2Oct 2026: 06 in 12 months
The Journal of Neuroscience

Contralesional brain aging links to stroke aphasia severity

In 188 individuals with chronic stroke, regional deviations from normative brain aging in the undamaged hemisphere accounted for aphasia severity and predicted…In 188 individuals with chronic stroke, regional deviations from normative brain aging in the undamaged hemisphere accounted for aphasia severity and predicted post-therapy recovery.

Cohort study of 188 peopleStroke